Details of the Drug
General Information of Drug (ID: DMGSKAO)
Drug Name |
1-(2-chlorophenyl)-3-(pyridin-2-yl)thiourea
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
NSC695051; MLS000665964; 1-(2-chlorophenyl)-3-pyridin-2-ylthiourea; CHEMBL1253185; SMR000294655; 1-(2-chlorophenyl)-3-(2-pyridyl)thiourea; N-(2-chlorophenyl)-N'-2-pyridinylthiourea; 61966-21-0; 1-(2-chlorophenyl)-3-(pyridin-2-yl)thiourea; AC1LJD94; cid_972361; CTK2C9582; BDBM47541; DTXSID20359567; MolPort-001-585-178; HMS2680I19; ZINC5933945; STK164730; AKOS002331850; NSC-695051; MCULE-5727736228; NCI60_034026; Thiourea, N-(chlorophenyl)-N'-2-pyridinyl-; ST50765308; 1-(2-chlorophenyl)-3-(2-pyridinyl)thiourea
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 263.75 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 3 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 2 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 2 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||